Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Innospace's rocket crashes in first commercial launch in Brazil; shares tumble - 2Track down Your Optimal Conservative Vehicle: Famous Brands to Consider
- 3Kiev declares energy emergency after Russian attacks amid winter cold
- 4Clovis Unified students spend spring break traveling through China
- 5The most effective method to Pick the Right Teeth Substitution Choice for You
- Analysis-From 'Icarus bug' to flawed panels: Airbus counts cost of relying on single model
- These 2 companies are teaming up to offer insurance for space debris strikes on satellites
- Vote In favor of Your Favored Kind Of Bites
- Kristin Cavallari was the teen queen bee of 'Laguna Beach.' Now she's a 'cringey' mom.
- Remarkable Spots for Hot Air Swelling All over The Planet
- What is the Insurrection Act? Can Trump really use the military to 'put an end' to Minneapolis ICE protests?
- Share your pick for the riding area that characterizes your surf undertakings!
- How did birds survive while dinosaurs went extinct?
- Corcept Therapeutics shares surge as lead drug gets FDA nod for ovarian cancer
